Advertisement
Screener

EDESA BIOTECH, INC. (EDSA) Increase (Decrease) in Prepaid Expense

2.8 / 5 stars · 68/120 Roast Me

EDESA BIOTECH, INC. Increase (Decrease) in Prepaid Expense

EDESA BIOTECH, INC. (EDSA) reported Increase (Decrease) in Prepaid Expense of -$339.03 thousand for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-09.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2023-08-09

  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for the quarter ending 2023-06-30 was -$198.18K, a 257.20% decline year-over-year.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for the quarter ending 2023-03-31 was -$198.57K, a 322.18% decline year-over-year.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for the quarter ending 2022-12-31 was $57.72K.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for the quarter ending 2022-09-30 was -$9.36K.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for fiscal 2022 was $19.50K, a 93.07% decline from fiscal 2021.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for fiscal 2021 was $281.36K.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for fiscal 2020 was -$404.07K.
  • EDESA BIOTECH, INC. increase (decrease) in prepaid expense for fiscal 2018 was -$81.66K.
Period endIncrease (Decrease) in Prepaid Expense 1 monthIncrease (Decrease) in Prepaid Expense 3 monthIncrease (Decrease) in Prepaid Expense 3 month as first filedIncrease (Decrease) in Prepaid Expense 6 monthIncrease (Decrease) in Prepaid Expense 6 month as first filedIncrease (Decrease) in Prepaid Expense 9 monthIncrease (Decrease) in Prepaid Expense 9 month as first filedIncrease (Decrease) in Prepaid Expense 12 monthIncrease (Decrease) in Prepaid Expense 12 month as first filed
2023-06-30-$198.18K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09
-$396.75K
derived: sum of 2 quarters · filed 2023-08-09
-$339.03K
10-Q · filed 2023-08-09
-$348.39K
derived: sum of 4 quarters · filed 2023-08-09
2023-03-31-$198.57K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11
-$140.85K
10-Q · filed 2023-05-11
-$150.21K
derived: sum of 3 quarters · filed 2023-05-11
-$24.15K
derived: sum of 4 quarters · filed 2023-08-09
2022-12-31$57.72K
10-Q · filed 2023-02-10
$48.36K
derived: sum of 2 quarters · filed 2023-02-10
$174.43K
derived: sum of 3 quarters · filed 2023-08-09
$263.80K
derived: sum of 4 quarters · filed 2023-08-09
2022-09-30-$9.36K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16
$116.71K
derived: sum of 2 quarters · filed 2023-08-09
$206.08K
derived: sum of 3 quarters · filed 2023-08-09
$19.50K
10-K · filed 2022-12-16
2022-06-30$126.07K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-09
$215.44K
derived: sum of 2 quarters · filed 2023-08-09
$28.86K
10-Q · filed 2023-08-09
-$1.08M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$89.38K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-11
-$97.21K
10-Q · filed 2023-05-11
-$1.20M
derived: sum of 3 quarters · filed 2023-05-11
-$1.74M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$186.58K
10-Q · filed 2023-02-10
-$1.29M
derived: sum of 2 quarters · filed 2023-02-10
-$1.83M
derived: sum of 3 quarters · filed 2023-02-10
$472.08K
derived: sum of 4 quarters · filed 2023-02-10
2021-09-30-$1.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-16
-$1.65M
derived: sum of 2 quarters · filed 2022-12-16
$658.67K
derived: sum of 3 quarters · filed 2022-12-16
$281.36K
10-K · filed 2022-12-16
-$281.36K
10-K · filed 2021-12-28
2021-06-30-$539.44K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-12
$1.77M
derived: sum of 2 quarters · filed 2022-08-12
$1.39M
10-Q · filed 2022-08-12
-$1.39M
10-Q · filed 2021-08-13
$1.12M
derived: sum of 4 quarters · filed 2022-08-12
2021-03-31$2.31M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13
$1.93M
10-Q · filed 2022-05-13
$1.66M
derived: sum of 3 quarters · filed 2022-05-13
$1.55M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$377.31K
10-Q · filed 2022-02-14
$377.31K
10-Q · filed 2021-02-16
-$646.71K
derived: sum of 2 quarters · filed 2022-02-14
-$754.34K
derived: sum of 3 quarters · filed 2022-02-14
-$772.11K
derived: sum of 4 quarters · filed 2022-02-14
2020-09-30-$269.40K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-28
-$377.04K
derived: sum of 2 quarters · filed 2021-12-28
-$394.80K
derived: sum of 3 quarters · filed 2021-12-28
-$404.07K
10-K · filed 2021-12-28
$404.07K
10-K · filed 2020-12-07
2020-06-30-$107.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-13
-$125.40K
derived: sum of 2 quarters · filed 2021-08-13
-$134.66K
10-Q · filed 2021-08-13
$134.66K
10-Q · filed 2020-08-12
-$88.97K
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31-$17.77K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-14
-$27.03K
10-Q · filed 2021-05-14
$18.67K
derived: sum of 3 quarters · filed 2021-05-14
$269.84K
derived: sum of 4 quarters · filed 2021-05-14
2019-12-31-$9.26K
10-Q · filed 2021-02-16
-$125.87K
10-Q · filed 2020-02-13
$36.43K
derived: sum of 2 quarters · filed 2021-02-16
$287.61K
derived: sum of 3 quarters · filed 2021-02-16
$302.36K
derived: sum of 4 quarters · filed 2021-02-16
2019-09-30$45.70K
derived: 10-K 9 month − 10-Q 6 month · filed 2020-12-07
$296.87K
derived: sum of 2 quarters · filed 2020-12-07
$311.47K
10-K · filed 2020-12-07
$305.59K
derived: sum of 4 quarters · filed 2020-12-07
2019-06-30$251.17K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-12
$265.77K
10-Q · filed 2019-08-14
$259.89K
10-Q · filed 2020-08-12
$245.03K
derived: sum of 4 quarters · filed 2020-08-12
2019-03-31$14.75K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15
$8.72K
10-Q · filed 2020-05-15
$83.91K
10-Q · filed 2019-05-08
-$6.15K
derived: sum of 3 quarters · filed 2020-05-15
-$114.30K
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31-$6.03K
10-Q · filed 2020-02-13
$127.92K
10-Q · filed 2019-02-05
-$20.90K
derived: sum of 2 quarters · filed 2020-02-13
-$129.05K
derived: sum of 3 quarters · filed 2020-02-13
-$81.66K
10-KT · filed 2019-12-12
2018-09-30-$14.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30
-$123.02K
derived: sum of 2 quarters · filed 2018-11-30
-$72.67K
derived: sum of 3 quarters · filed 2019-05-08
-$36.75K
10-K · filed 2018-11-30
2018-06-30-$108.15K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08
-$91.86K
10-Q · filed 2019-08-14
-$21.88K
10-Q · filed 2018-08-08
-$219.85K
derived: sum of 4 quarters · filed 2019-05-08
2018-03-31$50.35K
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-08
$86.27K
10-Q · filed 2019-05-08
-$111.70K
derived: sum of 3 quarters · filed 2019-05-08
-$166.78K
derived: sum of 4 quarters · filed 2019-05-08
2017-12-31$35.92K
10-Q · filed 2019-02-05
-$162.05K
derived: sum of 2 quarters · filed 2019-02-05
-$217.13K
derived: sum of 3 quarters · filed 2019-02-05
-$208.97K
derived: sum of 4 quarters · filed 2019-02-05
2017-09-30-$197.97K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-30
-$253.05K
derived: sum of 2 quarters · filed 2018-11-30
-$244.89K
derived: sum of 3 quarters · filed 2018-11-30
-$235.00K
10-K · filed 2018-11-30
2017-06-30-$55.09K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-08
-$46.92K
derived: sum of 2 quarters · filed 2018-08-08
-$37.03K
10-Q · filed 2018-08-08
$198.42K
derived: sum of 4 quarters · filed 2018-08-08
2017-03-31$8.17K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-07
$18.05K
10-Q · filed 2018-05-07
$253.50K
derived: sum of 3 quarters · filed 2018-05-07
$180.30K
derived: sum of 4 quarters · filed 2018-05-07
2016-12-31$9.88K
10-Q · filed 2018-02-07
$245.34K
derived: sum of 2 quarters · filed 2018-02-07
$172.13K
derived: sum of 3 quarters · filed 2018-02-07
$139.32K
derived: sum of 4 quarters · filed 2018-02-07
2016-09-30$235.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01
$162.24K
derived: sum of 2 quarters · filed 2017-12-01
$129.43K
derived: sum of 3 quarters · filed 2017-12-01
$197.15K
10-K · filed 2017-12-01
2016-06-30-$73.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-09
-$106.02K
derived: sum of 2 quarters · filed 2017-08-09
-$38.30K
10-Q · filed 2017-08-09
-$130.48K
derived: sum of 4 quarters · filed 2017-12-01
2016-03-31-$32.81K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-09
$34.91K
10-Q · filed 2017-05-09
-$57.27K
derived: sum of 3 quarters · filed 2017-12-01
$53.63K
derived: sum of 4 quarters · filed 2017-12-01
2015-12-31$67.72K
10-Q · filed 2017-02-06
-$24.46K
derived: sum of 2 quarters · filed 2017-12-01
$86.44K
derived: sum of 3 quarters · filed 2017-12-01
$149.94K
derived: sum of 4 quarters · filed 2017-12-01
2015-09-30-$92.18K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-01
$18.72K
derived: sum of 2 quarters · filed 2017-12-01
$82.23K
derived: sum of 3 quarters · filed 2017-12-01
$45.76K
10-K · filed 2017-12-01
2015-06-30$110.90K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-09
$174.41K
derived: sum of 2 quarters · filed 2016-08-09
$137.94K
10-Q · filed 2016-08-09
2015-03-31$63.51K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-09
$27.04K
10-Q · filed 2016-05-09
2014-12-31-$36.47K
10-Q · filed 2016-02-08
2014-09-30-$490.00
10-K · filed 2016-12-14
2014-08-31$94.97K
10-K · filed 2016-12-14
2014-06-30$76.40K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-10
$108.34K
derived: sum of 2 quarters · filed 2015-08-10
$106.24K
10-Q · filed 2015-08-10
2014-03-31$31.94K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-11
$29.84K
10-Q · filed 2015-05-11
2013-12-31-$2.10K
10-Q · filed 2015-02-09
2013-08-31$2.66K
10-K · filed 2015-12-14
2012-08-31-$4.38K
10-K · filed 2014-11-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Celularity Inc (CELU)United States$0.038B-0.34
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Kairos Pharma, LTD. (KAPA)United States$0.041B